Adma Biologics (ADMA) Intangibles (2017 - 2026)
Adma Biologics (ADMA) reported Intangibles of $575,000 for Q2 2026, up 9.1% from $527,000 a year earlier but down 8.7% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Intangibles (2017 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics posted Intangibles of $632,000, up 37.4% from FY2024.
- Intangibles has a five-year compound annual growth rate of -23.7% (FY2020 to FY2025).
- By year, Intangibles came in at $460,000 in FY2024 (-7.8%), $499,000 in FY2023 (-50.7%), $1.01 million in FY2022 (-41.4%) and $1.73 million in FY2021 (-29.3%).
- Five-year quarterly Intangibles spans a low of $321,000 in Q1 2024 and a high of $1.91 million in Q3 2021.
- Year over year, Intangibles has now increased in each of the last six quarters, with growth averaging 16.5% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q1 2025 (growth of 40.8%); the low point was Q1 2024 (a decline of 61.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $630,000 (Q1 2026), $632,000 (Q4 2025) and $491,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Adma Biologics | 2.24 Bn | 1.82 Bn | 86.28 Mn | 575,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 630,000.00 |
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 460,000.00 |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | 479,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 499,000.00 |
| Sep 30, 2023 | 476,902.00 |
| Jun 30, 2023 | 655,740.00 |
| Mar 31, 2023 | 834,577.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 1.91 Mn |
API Access
Adma Biologics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();